ES2160090A1 - Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration - Google Patents

Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Info

Publication number
ES2160090A1
ES2160090A1 ES200000635A ES200000635A ES2160090A1 ES 2160090 A1 ES2160090 A1 ES 2160090A1 ES 200000635 A ES200000635 A ES 200000635A ES 200000635 A ES200000635 A ES 200000635A ES 2160090 A1 ES2160090 A1 ES 2160090A1
Authority
ES
Spain
Prior art keywords
cyprofloxacin
otitis
aqueous
single dose
comprises single
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200000635A
Other languages
Spanish (es)
Other versions
ES2160090B1 (en
Inventor
Soler Pedro Canovas
Ramon Amat Elisabet De
Rueda Juan Moreno
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vita Invest SA
Original Assignee
Vita Invest SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vita Invest SA filed Critical Vita Invest SA
Priority to ES200000635A priority Critical patent/ES2160090B1/en
Publication of ES2160090A1 publication Critical patent/ES2160090A1/en
Application granted granted Critical
Publication of ES2160090B1 publication Critical patent/ES2160090B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

The set of aqueous cyprofloxacin otitis pharmaceuticals comprising single-dose products for treatment of perforated-eardrum patients, is new. Also claimed is a process utilizing the products in the form of droplets, topically, from single-dose containers.
ES200000635A 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration Expired - Fee Related ES2160090B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES200000635A ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES200000635A ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Publications (2)

Publication Number Publication Date
ES2160090A1 true ES2160090A1 (en) 2001-10-16
ES2160090B1 ES2160090B1 (en) 2002-07-01

Family

ID=8492728

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200000635A Expired - Fee Related ES2160090B1 (en) 2000-03-16 2000-03-16 Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration

Country Status (1)

Country Link
ES (1) ES2160090B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077360A2 (en) * 2004-02-05 2005-08-25 Fairfield Clinical Trials, Llc Topical treatment of otitis externa with antifungals or antibacterials

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088742A1 (en) * 1994-06-29 1996-08-16 Salvat Lab Sa Antibiotic preparation for aural application
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
EP0763359A1 (en) * 1995-07-14 1997-03-19 R.R.A. S.r.l. Pharmaceutical composition for topical use
ES2105971A1 (en) * 1995-08-02 1997-10-16 S A L V A T Lab Sa Antibiotic/anti-inflammatory composition for otic application.
ES2105970A1 (en) * 1995-08-02 1997-10-16 S A L V A T Lab Sa Oral pharmaceutical composition of ciprofloxacin, non- aqueous, stable and with improved organoleptic characteristics.
ES2106680A1 (en) * 1995-08-03 1997-11-01 Vita Invest Sa Aqueous compositions containing ciprofloxacine, and related use and process
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2088742A1 (en) * 1994-06-29 1996-08-16 Salvat Lab Sa Antibiotic preparation for aural application
WO1996039146A1 (en) * 1995-06-06 1996-12-12 Bayer Corporation Non-irritation, non-sensitizing, non-ototoxic otic antibacterial compositions
US5843930A (en) * 1995-06-06 1998-12-01 Bayer Corporation Method of treating otitis with ciprofloxacin-hydrocortisone suspension
EP0763359A1 (en) * 1995-07-14 1997-03-19 R.R.A. S.r.l. Pharmaceutical composition for topical use
ES2105971A1 (en) * 1995-08-02 1997-10-16 S A L V A T Lab Sa Antibiotic/anti-inflammatory composition for otic application.
ES2105970A1 (en) * 1995-08-02 1997-10-16 S A L V A T Lab Sa Oral pharmaceutical composition of ciprofloxacin, non- aqueous, stable and with improved organoleptic characteristics.
ES2106680A1 (en) * 1995-08-03 1997-11-01 Vita Invest Sa Aqueous compositions containing ciprofloxacine, and related use and process

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077360A2 (en) * 2004-02-05 2005-08-25 Fairfield Clinical Trials, Llc Topical treatment of otitis externa with antifungals or antibacterials
WO2005077360A3 (en) * 2004-02-05 2005-11-10 Fairfield Clinical Trials Llc Topical treatment of otitis externa with antifungals or antibacterials

Also Published As

Publication number Publication date
ES2160090B1 (en) 2002-07-01

Similar Documents

Publication Publication Date Title
UA74346C2 (en) Aminodicarboxylic acids derivatives, use thereof and a medicament
MX9602683A (en) 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds as pharmaceutically active substances.
MX9601399A (en) Benzocyclopentane oxazolidones containing heteroatoms, process for their production and medicaments containing them.
MXPA03007712A (en) Pharmaceutical salts.
BR0112591A (en) Acridine derivatives and their application as a medicine
CA2272584A1 (en) Novel substituted pyrazole derivatives for the treatment of cardiocirculatory diseases
CA2257329A1 (en) Nebulized budesonide for the treatment of respiratory diseases
IL136839A0 (en) Pharmaceutical compositions comprising cannabidiol derivatives
MX9605023A (en) Imidazolidine-2,4-dione substituted compounds, as pharmaceutically active substances.
PT703786E (en) USE OF NONAPEPTIDEES AND DECAPEPTIDEOS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF AIDS
ZA965752B (en) Triphenylethylenes, process for their production, pharmaceutical preparations that contain these triphenylethylenes as well as their use for the production of pharmaceutical agents.
IL152578A0 (en) Ortho-substituted anthranilic acid amides and their use as medicaments
CA2189916A1 (en) A new regime for paclitaxel in kaposi's sarcoma patients
IS6394A (en) Medicinal product containing solmitriptan
IL150528A0 (en) Ibuprofen containing active agent preparation
AU5372199A (en) Cyclopentabenzofuran derivatives and their use
HK1079688A1 (en) Statin product for enhancing cognitive maintenance
PL348781A1 (en) Soya extract containing lipids, process for its production, and pharmaceutical and cosmetic composition
ES2160090A1 (en) Set of aqueous cyprofloxacin otitis pharmaceuticals comprises single dose products treating perforated eardrums by dropwise administration
WO2001076590A3 (en) Treatment for benign positional vertigo using antiepileptics
MY127328A (en) 5-amino-1-pentene-3-ol substituted derivatives
WO2002041897A3 (en) Novel pharmaceutical compositions with anti-diabetic activity and method for preparing same
ZA200100289B (en) Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis.
PL367628A1 (en) Use of an alkanoyl l-carnitine for the preparation of a medication to treat anhedonia
WO2000067733A3 (en) Medicament for treating human infertility

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20011016

Kind code of ref document: A1

Effective date: 20011016

FD2A Announcement of lapse in spain

Effective date: 20200626